Reimagining Antibody Drug Discovery with AI
October 27, 2025
By focusing on functional activity, Abalone Bio is advancing CB2-targeting antibodies with the potential to transform treatment for fibrosis, neuropathy, and beyond.
6 min read
2025
Get Ready for CPHI: Off-Patent Semaglutide and Sustainability in a Shifting World
October 27, 2025
It’s showtime in Frankfurt – with around 62,000 attendees expected.
4 min read
MDIs and the Need for Greener Propellants
October 27, 2025
Regulations are pushing companies to more environmentally friendly propellants, but how should capacity be scaled up?
5 min read
Reimagining LSD to Treat Mental Health Disorders
October 24, 2025
We speak with a biotech CEO about the potential of psychedelic medicine – and the challenges of working with stigmatized substances.
11 min read
Hedgehogs, Seaweed, and the Future of Cell Logistics
October 24, 2025
How biology, sustainability, and a nod to the African pygmy hedgehog are reshaping how we move living cells around the world – and beyond.
6 min read
Made in Africa, For Global Good
October 23, 2025
Interviewing Quarraisha Abdool Karim – one of the world’s most influential HIV scientists
10 min read
Roving Reporter Asks: What Are the Biggest Hurdles in Cell and Gene Therapy Development?
October 23, 2025
IBTV interviews show that funding and investment panic are dominating industry concerns.
The Cell & Gene Circuit: Keeping Up With Advancing Therapies and Technologies
October 22, 2025
Cell and gene therapy is advancing faster than ever, powered by breakthroughs in AI, automation, and CRISPR technology. But as some companies double down and others step back, the race to deliver real-world impact is intensifying.
4 min read
Tariffs, Talent, and Technology: Inside Pharma’s Executive Recruitment Landscape
October 22, 2025
As tariffs and geopolitical uncertainty continue to disrupt supply chains, a new kind of biotech and pharma executive is emerging.
7 min read
The Power List Personified: Getting to Know Fabian Gerlinghaus
October 21, 2025
Cellares CEO Fabian Gerlinghaus talks about automation, partnerships, and inspiration from Carl June.
3 min read
